Medicare Plans’ Formulary Restrictions Will Get More Scrutiny In 2010 Bids – CMS
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency proposes that next year’s Part D bids report new drug utilization requirements in a clear and consistent way to make it easier to assess policy compliance.